The impact of metformin on survival in diabetic endometrial cancer patients: a retrospective population-based analysis
ConclusionOur study results suggest no beneficial impact on overall and cancer-specific survival in endometrial cancer patients who were treated with metformin as part of their diabetes treatment.
Source: Journal of Diabetes and Metabolic Disorders - Category: Endocrinology Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Endometrial Cancer | Fortamet | Health Insurance | Insurance | Lithuania Health | Metformin | Study | Women